Effect of short-term administration of garlic supplements on single-dose ritonavir pharmacokinetics in healthy volunteers

British Journal of Clinical Pharmacology

Volumn 55, Issue 2, 2003, Pages 199-202

  Gallicano, Keith ^a,b,f   Foster, Brian ^c   Choudhri, Shurjeel ^d,e  

^a Clinical Investigation Unit   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^c HEALTH CANADA   (Canada)

^d UNIVERSITY OF MANITOBA   (Canada)

^e ST BONIFACE GENERAL HOSPITAL   (Canada)

^f Axelson Biopharma Research Inc   (Canada)

Author keywords

Garlic supplements; Pharmacokinetic interaction; Ritonavir

Indexed keywords

GARLIC EXTRACT; RITONAVIR;

ADULT; ARTICLE; CLINICAL TRIAL; CROSSOVER PROCEDURE; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG METABOLISM; FEMALE; FOOD DRUG INTERACTION; GARLIC; HUMAN; MALE; MEAL; NORMAL HUMAN; OPEN STUDY; PRIORITY JOURNAL; TIME SERIES ANALYSIS;

ADMINISTRATION, ORAL; ANALYSIS OF VARIANCE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROSS-OVER STUDIES; FEMALE; GARLIC; HIV PROTEASE INHIBITORS; HUMANS; MALE; PLANT EXTRACTS; PLANT PREPARATIONS; RITONAVIR;

EID: 0037329811     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.2003.01736.x     Document Type: Article

References (8)

1. Foster BC, Foster MS, Vandenhoek S et al. An in vitro evaluation of human cytochrome P450 3A4 and P-glycoprotein inhibition by garlic. J Pharm Pharmaceut Sci 2001; 4: 176-184.
2. Dalvi RR. Alterations in hepatic phase I and phase II biotransformation enzymes by garlic oil in rats. Toxicol Lett 1992; 60: 299-305.
3. Haber D, Siess MH, de Waziers I, Beaune P, Suschetet M. Modification of hepatic drug-metabolizing enzymes in rat fed naturally occurring allyl sulphides. Xenobiotica 1994; 24: 169-182.
4. Piscitelli SC, Burstein AH, Welden N, Gallicano KD, Falloon J. The effect of garlic supplements on the pharmacokinetics of saquinavir. Clin Infect Dis 2002; 34: 234-238.
5. Laroche M, Choudhri S, Gallicano K, Foster B. Severe gastrointestinal toxicity with concomitant ingestion of ritonavir and garlic. Can J Infect Dis 1998; 9 (Suppl A): 471P. (Abstr.).
6. Hsu A, Granneman GR, Bertz RJ. Ritonavir: clinical pharmacokinetics and interactions with other anti-HIV agents. Clin Pharmacokinet 1998; 35: 275-291.
7. Khaliq Y, Gallicano K, Venance S, Kravcik S, Cameron DW. Effect of ketoconazole on ritonavir and saquinavir concentrations in plasma and cerebrospinal fluid from patients infected with human immunodeficiency virus. Clin Pharmacol Ther 2000; 68: 637-646.
8. Lawson LD, Wang Z-YJ, Hughes BG. Identification and HPLC quantitation of the sulfides and dialk(en)yl thiosulfates in commercial garlic products. Planta Med 1991; 57: 363-370.